Structure

Physi-Chem Properties

Molecular Weight:  1261.72
Volume:  1288.544
LogP:  3.69
LogD:  3.596
LogS:  -2.978
# Rotatable Bonds:  20
TPSA:  355.01
# H-Bond Aceptor:  25
# H-Bond Donor:  10
# Rings:  7
# Heavy Atoms:  25

MedChem Properties

QED Drug-Likeness Score:  0.061
Synthetic Accessibility Score:  7.333
Fsp3:  0.606
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.468
MDCK Permeability:  0.00015522413013968617
Pgp-inhibitor:  0.18
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  1.0
20% Bioavailability (F20%):  0.914
30% Bioavailability (F30%):  0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.105
Plasma Protein Binding (PPB):  57.888797760009766%
Volume Distribution (VD):  0.731
Pgp-substrate:  27.095348358154297%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.001
CYP2C19-inhibitor:  0.038
CYP2C19-substrate:  0.039
CYP2C9-inhibitor:  0.09
CYP2C9-substrate:  0.905
CYP2D6-inhibitor:  0.382
CYP2D6-substrate:  0.073
CYP3A4-inhibitor:  0.145
CYP3A4-substrate:  0.016

ADMET: Excretion

Clearance (CL):  0.828
Half-life (T1/2):  0.715

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  1.0
Drug-inuced Liver Injury (DILI):  0.99
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.955
Maximum Recommended Daily Dose:  0.937
Skin Sensitization:  0.574
Carcinogencity:  0.188
Eye Corrosion:  0.003
Eye Irritation:  0.003
Respiratory Toxicity:  0.903

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473002

Natural Product ID:  NPC473002
Common Name*:   JUWGVTIMYSVRDI-KONYCJQDSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  JUWGVTIMYSVRDI-KONYCJQDSA-N
Standard InCHI:  InChI=1S/C66H95N13O12/c1-9-40(7)54(60(85)69-37-52(67)80)75-62(87)55(41(8)10-2)74-59(84)49-26-18-30-77(49)65(90)47-36-68-45(34-42-21-13-11-14-22-42)63(88)76-29-17-25-48(76)57(82)70-44(33-38(3)4)56(81)71-46(35-43-23-15-12-16-24-43)64(89)79-32-20-28-51(79)66(91)78-31-19-27-50(78)58(83)73-53(39(5)6)61(86)72-47/h11-16,21-24,36,38-41,44-46,48-51,53-55,68H,9-10,17-20,25-35,37H2,1-8H3,(H2,67,80)(H,69,85)(H,70,82)(H,71,81)(H,72,86)(H,73,83)(H,74,84)(H,75,87)/b47-36-/t40-,41-,44-,45-,46-,48-,49-,50-,51-,53-,54-,55-/m0/s1
SMILES:  CC[C@@H]([C@@H](C(=N[C@H](C(=NCC(=N)O)O)[C@H](CC)C)O)N=C([C@@H]1CCCN1C(=O)/C/1=C/N[C@@H](Cc2ccccc2)C(=O)N2CCC[C@H]2C(=N[C@@H](CC(C)C)C(=N[C@H](C(=O)N2[C@H](C(=O)N3[C@H](C(=N[C@H](C(=N1)O)C(C)C)O)CCC3)CCC2)Cc1ccccc1)O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3597658
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0003297] Organic Polymers
      • [CHEMONTID:0003298] Polypeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16915 Callyspongia aerizusa Species Callyspongiidae Eukaryota n.a. n.a. n.a. PMID[26213786]
NPO16915 Callyspongia aerizusa Species Callyspongiidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1970 Cell Line THP-1 Homo sapiens IC50 > 10000.0 nM PMID[470916]
NPT171 Cell Line MRC5 Homo sapiens IC50 > 10000.0 nM PMID[470916]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC90 > 100000.0 nM PMID[470916]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473002 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9658 High Similarity NPC469902
0.9658 High Similarity NPC473003
0.9384 High Similarity NPC469903
0.9276 High Similarity NPC469904
0.9067 High Similarity NPC469898
0.8924 High Similarity NPC473001
0.8882 High Similarity NPC469901
0.8662 High Similarity NPC473000
0.8625 High Similarity NPC469900
0.8582 High Similarity NPC200589
0.8242 Intermediate Similarity NPC472999
0.8014 Intermediate Similarity NPC255447
0.7973 Intermediate Similarity NPC141050
0.7943 Intermediate Similarity NPC200964
0.7925 Intermediate Similarity NPC324850
0.7891 Intermediate Similarity NPC130309
0.7877 Intermediate Similarity NPC473322
0.7805 Intermediate Similarity NPC141957
0.7762 Intermediate Similarity NPC71684
0.7742 Intermediate Similarity NPC262077
0.7697 Intermediate Similarity NPC132636
0.7669 Intermediate Similarity NPC241794
0.7662 Intermediate Similarity NPC77905
0.7643 Intermediate Similarity NPC240848
0.7635 Intermediate Similarity NPC111428
0.759 Intermediate Similarity NPC302597
0.7582 Intermediate Similarity NPC89489
0.7564 Intermediate Similarity NPC315266
0.7562 Intermediate Similarity NPC122590
0.7552 Intermediate Similarity NPC470546
0.755 Intermediate Similarity NPC287401
0.7535 Intermediate Similarity NPC239357
0.7529 Intermediate Similarity NPC307396
0.75 Intermediate Similarity NPC476978
0.75 Intermediate Similarity NPC52748
0.7483 Intermediate Similarity NPC470545
0.7453 Intermediate Similarity NPC5194
0.7453 Intermediate Similarity NPC261934
0.7453 Intermediate Similarity NPC202198
0.7432 Intermediate Similarity NPC101719
0.7415 Intermediate Similarity NPC6975
0.7413 Intermediate Similarity NPC315276
0.7413 Intermediate Similarity NPC285926
0.7413 Intermediate Similarity NPC14672
0.7413 Intermediate Similarity NPC470544
0.7375 Intermediate Similarity NPC2501
0.7368 Intermediate Similarity NPC477462
0.7368 Intermediate Similarity NPC136797
0.7365 Intermediate Similarity NPC222466
0.7365 Intermediate Similarity NPC22746
0.7351 Intermediate Similarity NPC300315
0.7342 Intermediate Similarity NPC316008
0.7342 Intermediate Similarity NPC209509
0.7342 Intermediate Similarity NPC313867
0.7329 Intermediate Similarity NPC475168
0.7329 Intermediate Similarity NPC7817
0.7325 Intermediate Similarity NPC161069
0.7318 Intermediate Similarity NPC276430
0.7312 Intermediate Similarity NPC471820
0.7312 Intermediate Similarity NPC471821
0.7296 Intermediate Similarity NPC314358
0.7279 Intermediate Similarity NPC202521
0.7278 Intermediate Similarity NPC315283
0.7278 Intermediate Similarity NPC314388
0.7244 Intermediate Similarity NPC178662
0.7244 Intermediate Similarity NPC476133
0.7244 Intermediate Similarity NPC470884
0.7244 Intermediate Similarity NPC92784
0.7244 Intermediate Similarity NPC98424
0.7211 Intermediate Similarity NPC476990
0.7209 Intermediate Similarity NPC475532
0.7195 Intermediate Similarity NPC470902
0.7181 Intermediate Similarity NPC46427
0.7168 Intermediate Similarity NPC165285
0.7143 Intermediate Similarity NPC16188
0.7143 Intermediate Similarity NPC138775
0.7134 Intermediate Similarity NPC56685
0.7125 Intermediate Similarity NPC5620
0.7114 Intermediate Similarity NPC252878
0.7083 Intermediate Similarity NPC276085
0.7076 Intermediate Similarity NPC328649
0.7073 Intermediate Similarity NPC233702
0.7067 Intermediate Similarity NPC474082
0.7067 Intermediate Similarity NPC175726
0.7066 Intermediate Similarity NPC197743
0.7066 Intermediate Similarity NPC297145
0.7059 Intermediate Similarity NPC189116
0.7053 Intermediate Similarity NPC54420
0.7051 Intermediate Similarity NPC248283
0.7044 Intermediate Similarity NPC263493
0.7044 Intermediate Similarity NPC269398
0.7039 Intermediate Similarity NPC477937
0.7037 Intermediate Similarity NPC311658
0.7035 Intermediate Similarity NPC129486
0.7034 Intermediate Similarity NPC33742
0.703 Intermediate Similarity NPC262166
0.6994 Remote Similarity NPC198254
0.6994 Remote Similarity NPC274198
0.6993 Remote Similarity NPC319766
0.6989 Remote Similarity NPC171317
0.6982 Remote Similarity NPC471527
0.6981 Remote Similarity NPC239762
0.6981 Remote Similarity NPC163392
0.6979 Remote Similarity NPC162860
0.6971 Remote Similarity NPC17698
0.6962 Remote Similarity NPC471264
0.6962 Remote Similarity NPC471265
0.6959 Remote Similarity NPC220698
0.6959 Remote Similarity NPC63931
0.6951 Remote Similarity NPC129666
0.6941 Remote Similarity NPC68650
0.6928 Remote Similarity NPC473341
0.6923 Remote Similarity NPC62104
0.6923 Remote Similarity NPC1390
0.6901 Remote Similarity NPC471051
0.6901 Remote Similarity NPC471052
0.6901 Remote Similarity NPC471053
0.6897 Remote Similarity NPC276506
0.6882 Remote Similarity NPC469243
0.6855 Remote Similarity NPC127741
0.6851 Remote Similarity NPC96016
0.6849 Remote Similarity NPC35850
0.6849 Remote Similarity NPC276949
0.6848 Remote Similarity NPC283783
0.6836 Remote Similarity NPC196243
0.6832 Remote Similarity NPC476989
0.6829 Remote Similarity NPC329761
0.6829 Remote Similarity NPC225648
0.6824 Remote Similarity NPC24617
0.6821 Remote Similarity NPC61004
0.6818 Remote Similarity NPC242269
0.681 Remote Similarity NPC477217
0.681 Remote Similarity NPC322878
0.681 Remote Similarity NPC201244
0.6804 Remote Similarity NPC107077
0.6804 Remote Similarity NPC223791
0.6792 Remote Similarity NPC314835
0.6784 Remote Similarity NPC475544
0.6784 Remote Similarity NPC114806
0.6781 Remote Similarity NPC474584
0.6763 Remote Similarity NPC217804
0.6763 Remote Similarity NPC223207
0.6763 Remote Similarity NPC5719
0.6763 Remote Similarity NPC22883
0.6763 Remote Similarity NPC210377
0.676 Remote Similarity NPC269750
0.676 Remote Similarity NPC194671
0.6747 Remote Similarity NPC254798
0.6743 Remote Similarity NPC280022
0.6734 Remote Similarity NPC238945
0.6727 Remote Similarity NPC135121
0.6727 Remote Similarity NPC145113
0.6725 Remote Similarity NPC244336
0.6724 Remote Similarity NPC471771
0.6724 Remote Similarity NPC304074
0.6724 Remote Similarity NPC290755
0.6724 Remote Similarity NPC15068
0.6723 Remote Similarity NPC137627
0.6722 Remote Similarity NPC91179
0.6707 Remote Similarity NPC473491
0.6687 Remote Similarity NPC139326
0.6687 Remote Similarity NPC105717
0.6687 Remote Similarity NPC197682
0.6686 Remote Similarity NPC63040
0.6685 Remote Similarity NPC279871
0.6685 Remote Similarity NPC318930
0.6685 Remote Similarity NPC326407
0.6685 Remote Similarity NPC317362
0.6685 Remote Similarity NPC317725
0.6685 Remote Similarity NPC26108
0.6667 Remote Similarity NPC300443
0.6667 Remote Similarity NPC314114
0.6667 Remote Similarity NPC307357
0.6667 Remote Similarity NPC476259
0.6667 Remote Similarity NPC326349
0.6667 Remote Similarity NPC162104
0.6667 Remote Similarity NPC46098
0.6667 Remote Similarity NPC323336
0.6667 Remote Similarity NPC268841
0.6647 Remote Similarity NPC473580
0.6645 Remote Similarity NPC27833
0.6644 Remote Similarity NPC319579
0.663 Remote Similarity NPC153554
0.6629 Remote Similarity NPC306804
0.6628 Remote Similarity NPC104345
0.6628 Remote Similarity NPC222029
0.6626 Remote Similarity NPC168113
0.6625 Remote Similarity NPC474473
0.6615 Remote Similarity NPC472538
0.661 Remote Similarity NPC475123
0.661 Remote Similarity NPC475204
0.6605 Remote Similarity NPC122553
0.6597 Remote Similarity NPC106118
0.6595 Remote Similarity NPC17059
0.6585 Remote Similarity NPC468984
0.6585 Remote Similarity NPC176226
0.6582 Remote Similarity NPC475259
0.6582 Remote Similarity NPC471945
0.6582 Remote Similarity NPC471950
0.6582 Remote Similarity NPC470491

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473002 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.831 Intermediate Similarity NPD5339 Clinical (unspecified phase)
0.8069 Intermediate Similarity NPD7979 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD7728 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD4782 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD4791 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD8290 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6631 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD5263 Approved
0.7415 Intermediate Similarity NPD3072 Approved
0.7415 Intermediate Similarity NPD3073 Approved
0.7415 Intermediate Similarity NPD3071 Approved
0.7389 Intermediate Similarity NPD5341 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6901 Phase 3
0.7351 Intermediate Similarity NPD4676 Approved
0.7347 Intermediate Similarity NPD4761 Approved
0.7347 Intermediate Similarity NPD4762 Approved
0.7325 Intermediate Similarity NPD8076 Discontinued
0.7325 Intermediate Similarity NPD7720 Phase 2
0.7318 Intermediate Similarity NPD8240 Discontinued
0.7317 Intermediate Similarity NPD7267 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6073 Approved
0.7255 Intermediate Similarity NPD3632 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD8630 Approved
0.7179 Intermediate Similarity NPD5725 Approved
0.7179 Intermediate Similarity NPD8173 Phase 2
0.7179 Intermediate Similarity NPD8172 Phase 2
0.7171 Intermediate Similarity NPD4175 Approved
0.7171 Intermediate Similarity NPD4177 Approved
0.7126 Intermediate Similarity NPD8022 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD8643 Discontinued
0.7114 Intermediate Similarity NPD4706 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5301 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6919 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD2584 Suspended
0.7066 Intermediate Similarity NPD7118 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD6368 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD2585 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7602 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD4504 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD4126 Approved
0.702 Intermediate Similarity NPD4677 Discontinued
0.7006 Intermediate Similarity NPD7113 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD3908 Approved
0.6987 Remote Similarity NPD7634 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6088 Approved
0.6944 Remote Similarity NPD6557 Phase 2
0.6923 Remote Similarity NPD5581 Approved
0.6914 Remote Similarity NPD6860 Clinical (unspecified phase)
0.6903 Remote Similarity NPD4125 Approved
0.6903 Remote Similarity NPD6359 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5747 Discontinued
0.6839 Remote Similarity NPD3040 Approved
0.6835 Remote Similarity NPD6623 Phase 3
0.6835 Remote Similarity NPD8416 Discontinued
0.6821 Remote Similarity NPD8303 Discontinued
0.6813 Remote Similarity NPD4077 Clinical (unspecified phase)
0.681 Remote Similarity NPD5265 Approved
0.681 Remote Similarity NPD5264 Approved
0.6776 Remote Similarity NPD8103 Clinical (unspecified phase)
0.6774 Remote Similarity NPD4151 Approved
0.6772 Remote Similarity NPD941 Approved
0.6747 Remote Similarity NPD7892 Clinical (unspecified phase)
0.673 Remote Similarity NPD5323 Approved
0.6727 Remote Similarity NPD8323 Discontinued
0.6709 Remote Similarity NPD1329 Clinical (unspecified phase)
0.6709 Remote Similarity NPD1330 Phase 2
0.6708 Remote Similarity NPD6295 Approved
0.6708 Remote Similarity NPD6294 Approved
0.6708 Remote Similarity NPD6852 Discontinued
0.6707 Remote Similarity NPD979 Approved
0.6707 Remote Similarity NPD5024 Approved
0.6687 Remote Similarity NPD4757 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6632 Clinical (unspecified phase)
0.6667 Remote Similarity NPD951 Approved
0.6667 Remote Similarity NPD7613 Discontinued
0.6667 Remote Similarity NPD1968 Approved
0.6667 Remote Similarity NPD1967 Approved
0.6667 Remote Similarity NPD5748 Phase 2
0.6646 Remote Similarity NPD4794 Discontinued
0.6625 Remote Similarity NPD4153 Approved
0.6625 Remote Similarity NPD5296 Approved
0.6624 Remote Similarity NPD1781 Discontinued
0.6624 Remote Similarity NPD5759 Approved
0.6613 Remote Similarity NPD7617 Discontinued
0.6604 Remote Similarity NPD5299 Approved
0.6604 Remote Similarity NPD2078 Clinical (unspecified phase)
0.6587 Remote Similarity NPD3510 Approved
0.6587 Remote Similarity NPD3509 Approved
0.6585 Remote Similarity NPD2087 Approved
0.6585 Remote Similarity NPD2088 Approved
0.6564 Remote Similarity NPD4158 Clinical (unspecified phase)
0.6561 Remote Similarity NPD3588 Discontinued
0.6561 Remote Similarity NPD3604 Clinical (unspecified phase)
0.6561 Remote Similarity NPD3608 Clinical (unspecified phase)
0.6556 Remote Similarity NPD3806 Clinical (unspecified phase)
0.6543 Remote Similarity NPD8125 Discontinued
0.6543 Remote Similarity NPD5004 Approved
0.6541 Remote Similarity NPD4497 Clinical (unspecified phase)
0.6538 Remote Similarity NPD6792 Phase 3
0.6538 Remote Similarity NPD5367 Discontinued
0.6536 Remote Similarity NPD7964 Clinical (unspecified phase)
0.6536 Remote Similarity NPD7965 Phase 2
0.6531 Remote Similarity NPD8493 Clinical (unspecified phase)
0.6531 Remote Similarity NPD8322 Phase 2
0.6519 Remote Similarity NPD3626 Phase 3
0.6519 Remote Similarity NPD7828 Discontinued
0.6509 Remote Similarity NPD4432 Discontinued
0.6509 Remote Similarity NPD5941 Approved
0.6509 Remote Similarity NPD5942 Approved
0.6503 Remote Similarity NPD4214 Discontinued
0.6497 Remote Similarity NPD3029 Clinical (unspecified phase)
0.6494 Remote Similarity NPD7599 Phase 2
0.6491 Remote Similarity NPD8315 Phase 1
0.6491 Remote Similarity NPD6670 Clinical (unspecified phase)
0.6484 Remote Similarity NPD7771 Discontinued
0.6474 Remote Similarity NPD7105 Phase 1
0.6471 Remote Similarity NPD6078 Clinical (unspecified phase)
0.6467 Remote Similarity NPD747 Discontinued
0.6457 Remote Similarity NPD7600 Phase 2
0.6446 Remote Similarity NPD6681 Discovery
0.6437 Remote Similarity NPD4517 Clinical (unspecified phase)
0.6433 Remote Similarity NPD2031 Discontinued
0.6429 Remote Similarity NPD6552 Clinical (unspecified phase)
0.6429 Remote Similarity NPD5681 Clinical (unspecified phase)
0.6429 Remote Similarity NPD8362 Clinical (unspecified phase)
0.642 Remote Similarity NPD4565 Clinical (unspecified phase)
0.642 Remote Similarity NPD4564 Clinical (unspecified phase)
0.6409 Remote Similarity NPD6613 Clinical (unspecified phase)
0.6407 Remote Similarity NPD3508 Approved
0.6391 Remote Similarity NPD3519 Discontinued
0.6387 Remote Similarity NPD5187 Clinical (unspecified phase)
0.6386 Remote Similarity NPD2022 Approved
0.6374 Remote Similarity NPD6144 Discontinued
0.637 Remote Similarity NPD7130 Phase 3
0.6369 Remote Similarity NPD7484 Phase 3
0.6369 Remote Similarity NPD7485 Phase 3
0.6364 Remote Similarity NPD6655 Clinical (unspecified phase)
0.6359 Remote Similarity NPD3989 Phase 3
0.6353 Remote Similarity NPD2016 Approved
0.6353 Remote Similarity NPD2013 Approved
0.6353 Remote Similarity NPD2014 Approved
0.6343 Remote Similarity NPD7011 Discontinued
0.6331 Remote Similarity NPD2887 Clinical (unspecified phase)
0.633 Remote Similarity NPD7683 Discontinued
0.6325 Remote Similarity NPD7512 Approved
0.6325 Remote Similarity NPD7511 Approved
0.6324 Remote Similarity NPD3990 Phase 3
0.631 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6287 Remote Similarity NPD3625 Discontinued
0.6286 Remote Similarity NPD6855 Clinical (unspecified phase)
0.6284 Remote Similarity NPD4091 Approved
0.6279 Remote Similarity NPD5230 Approved
0.6279 Remote Similarity NPD5229 Approved
0.6278 Remote Similarity NPD6304 Approved
0.6278 Remote Similarity NPD6303 Approved
0.6271 Remote Similarity NPD7080 Clinical (unspecified phase)
0.6264 Remote Similarity NPD8126 Clinical (unspecified phase)
0.6264 Remote Similarity NPD8124 Phase 3
0.6258 Remote Similarity NPD3561 Clinical (unspecified phase)
0.6257 Remote Similarity NPD3988 Approved
0.6257 Remote Similarity NPD3282 Phase 1
0.6257 Remote Similarity NPD3283 Phase 3
0.6257 Remote Similarity NPD3987 Approved
0.6257 Remote Similarity NPD5614 Approved
0.6257 Remote Similarity NPD5613 Approved
0.6256 Remote Similarity NPD7780 Approved
0.6256 Remote Similarity NPD7781 Approved
0.6256 Remote Similarity NPD7621 Clinical (unspecified phase)
0.625 Remote Similarity NPD2437 Approved
0.625 Remote Similarity NPD2436 Approved
0.625 Remote Similarity NPD4092 Approved
0.6243 Remote Similarity NPD7968 Clinical (unspecified phase)
0.6236 Remote Similarity NPD8351 Phase 2
0.6235 Remote Similarity NPD2046 Approved
0.6235 Remote Similarity NPD2043 Approved
0.6235 Remote Similarity NPD2044 Approved
0.6235 Remote Similarity NPD2047 Approved
0.6235 Remote Similarity NPD2048 Approved
0.6235 Remote Similarity NPD2049 Clinical (unspecified phase)
0.6235 Remote Similarity NPD2045 Approved
0.6235 Remote Similarity NPD2051 Approved
0.6235 Remote Similarity NPD21 Approved
0.6235 Remote Similarity NPD2050 Clinical (unspecified phase)
0.623 Remote Similarity NPD5200 Clinical (unspecified phase)
0.6228 Remote Similarity NPD6897 Clinical (unspecified phase)
0.6228 Remote Similarity NPD7450 Phase 2
0.6226 Remote Similarity NPD5578 Approved
0.6226 Remote Similarity NPD3125 Approved
0.6226 Remote Similarity NPD5577 Clinical (unspecified phase)
0.6225 Remote Similarity NPD7971 Clinical (unspecified phase)
0.6225 Remote Similarity NPD7970 Approved
0.6225 Remote Similarity NPD480 Approved
0.6221 Remote Similarity NPD4682 Phase 2
0.622 Remote Similarity NPD5272 Discontinued
0.6215 Remote Similarity NPD4557 Approved
0.6215 Remote Similarity NPD4566 Approved
0.6215 Remote Similarity NPD4567 Approved
0.6211 Remote Similarity NPD5851 Approved
0.6211 Remote Similarity NPD5852 Approved
0.6209 Remote Similarity NPD1348 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data